{
    "Trade/Device Name(s)": [
        "VARIANTnbs Sickle Cell Program",
        "VARIANTnbs Newborn Screening System",
        "VARIANTnbs Sickle Cell Program Reagent Kit"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc.",
    "510(k) Number": "K080911",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051072"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKA"
    ],
    "Summary Letter Date": "May 2, 2008",
    "Summary Letter Received Date": "April 2, 2008",
    "Submission Date": "April 1, 2008",
    "Regulation Number(s)": [
        "21 CFR 864.7415"
    ],
    "Regulation Name(s)": [
        "Abnormal Hemoglobin Assay"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin F",
        "Hemoglobin A",
        "Hemoglobin S",
        "Hemoglobin D",
        "Hemoglobin C",
        "Hemoglobin E"
    ],
    "Specimen Type(s)": [
        "Eluates of neonatal blood collected on filter paper"
    ],
    "Specimen Container(s)": [
        "Filter paper"
    ],
    "Instrument(s)/Platform(s)": [
        "VARIANTnbs Newborn Screening System"
    ],
    "Method(s)/Technology(ies)": [
        "High-performance liquid chromatography (HPLC)",
        "Cation exchange chromatography"
    ],
    "Methodologies": [
        "Chromatographic separation"
    ],
    "Submission Type(s)": [
        "System",
        "Reagent Kit",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad VARIANTnbs Sickle Cell Program running on VARIANTnbs Newborn Screening System with GDM 3.0 software for qualitative screening of abnormal hemoglobins in neonatal blood.",
    "Indications for Use Summary": "Qualitative screening for hemoglobins F, A, S, D, C, and E in eluates of neonatal blood collected on filter paper to aid early diagnosis of sickle cell disease or trait.",
    "fda_folder": "Hematology"
}